,
Acs Fall 2024 Vvd-130037 Vvd1300373

Acs Fall 2024 Vvd-130037 Vvd1300373. Vividion has already disclosed work on covalent keap1 inhibitors, but at the recent acs fall 2024 meeting, the structure and discovery story of their clinical oral. Technical sessions, networking, career development & more.


Acs Fall 2024 Vvd-130037 Vvd1300373

Technical sessions, networking, career development & more. Choose from thousands of presentations, network, attend courses and visit the expo.

Acs Fall 2024 Vvd-130037 Vvd1300373 Images References :

More Details